StonvexLoading…
StonvexStonvexStonvexCore line items from MORN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.45B | $2.28B | $2.04B | $1.87B |
Operating Income | $526.60M | $484.80M | $230.60M | $167.80M |
Net Income | $374.20M | $369.90M | $141.10M | $70.50M |
EPS (Diluted) | $8.87 | $8.58 | $3.29 | $1.64 |
Total Assets | $3.59B | $3.55B | $3.40B | $3.47B |
Total Liabilities | $2.37B | $1.93B | $2.08B | $2.27B |
Cash & Equivalents | $474.50M | $502.70M | $337.90M | $376.60M |
Free Cash Flow OCF − CapEx | $442.60M | $448.90M | $197.30M | $168.30M |
Shares Outstanding | 39.74M | 42.87M | 42.73M | 42.48M |